Sulfatide is abundantly expressed in mammalian organs, including the intestine and trachea, in which influenza A viruses (IAVs) replicate. Sulfatide binds to IAV particles and inhibits the viral sialidase activity under low-pH conditions [1, 2] . Sulfatide is synthesized by two transferases, ceramide galactosyltransferase (CGT) and cerebroside sulfotransferase (CST), and is degraded by arylsulfatase A (ASA). In previous study, we demonstrated that association of sulfatide with These findings suggested that association of newly synthesized HA to sulfatide on the cell surface was an initial signal for increasing nuclear export of vRNP and that inhibitors of HA binding to sulfatide could be useful as novel anti-IAV agents [3] . However, it is not known whether there is direct binding of HA to sulfatide. In this study, we found that recombinant HA, which was produced by a baculovirus protein expression system from the HA gene of duck/HK/313/4/78 (H5N3), bound to sulfatide in a dose-dependent manner and that the binding was inhibited by a specific antibody [4] . Our results indicate that the recombinant HA is useful for elucidation of the binding domain of HA with sulfatide and for the development of new anti-IAV agents.
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